Improving Biotherapeutic Analysis With an Inert Flow Path

Discover how an inert flow path can reduce nonspecific adsorption and improve recovery, peak shape, and aggregate quantitation for biotherapeutics. See real-world SEC and RP-HPLC data for proteins, monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and GLP-1 therapeutics.

Register Free: https://www.chromatographyonline.com/ca_w/flow-path

Event Overview:

Biotherapeutic analyses can be impacted by nonspecific interactions with metal surfaces, resulting in reduced recovery, peak tailing, and compromised quantitation. This webinar demonstrates how inert flow path technology minimizes adsorption and improves performance for peptides, proteins, monoclonal antibodies, antibody-drug conjugates, and GLP-1 therapeutics across SEC and RP-HPLC workflows.

Key Learning Objectives

• How metal surfaces impact biomolecule separations.
• How improving flow path inertness can improve peak shape and analyte recovery.
• Optimizing SEC methods for biotherapeutic characterization.

Speakers

Dr. Anne Blackwell
Product Manager, Bio LC Columns
Agilent Technologies

Dr. Anne Blackwell holds a Ph.D. in analytical chemistry from the University of Arizona, with expertise in mass spectrometry of protein assemblies. She is a Product Manager for Bio LC Columns at Agilent Technologies.

Dr. Daniel Meston
Application Development Scientist
Agilent Technologies

Dr. Daniel Meston holds a Ph.D. in bioanalytical chemistry and has spent 10 years researching bioseparation mechanisms and 2D-LC/MS methods for biotherapeutics analysis. He is an Application Development Scientist at Agilent Technologies.

Register Free: https://www.chromatographyonline.com/ca_w/flow-path